Overview
Ana Oton is an Oncologist practicing medicine in Denver, Colorado.
Dr. Oton is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Desmoid Tumor, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
She is actively involved in clinical research, co-authoring 21 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
777 Bannock St # 7782, Denver, CO 80204
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Rocky Mountain Cancer Centers
John Burke is an Oncologist practicing medicine in Aurora, Colorado. Dr. Burke is highly rated in 66 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Classical Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Nephrectomy. Dr. Burke is board certified in American Board Of Internal Medicine. Dr. Burke is currently accepting new patients.
Colorado Blood Cancer Institute
Jeffrey Matous is an Oncologist practicing medicine in Denver, Colorado. Dr. Matous is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Matous is currently accepting new patients.
Children's Hospital Colorado
Rajeev Vibhakar is a Hematologist and an Oncologist practicing medicine in Aurora, Colorado. Dr. Vibhakar is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Gliomatosis Cerebri. Dr. Vibhakar is currently accepting new patients.
Frequently Asked Questions about Dr. Ana B. Oton
How do I make an appointment with Dr. Ana B. Oton?
You can book an appointment with Dr. Ana B. Oton by calling their office at 800-555-1212. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ana B. Oton a top-rated expert for Desmoid Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ana B. Oton is classified as an Distinguished expert for Desmoid Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ana B. Oton specialize in?
While Dr. Ana B. Oton is a Oncology, they have specific expertise in Desmoid Tumor, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Ana B. Oton participate in research or clinical trials?
Yes. Dr. Ana B. Oton has published 21 articles and abstracts on conditions like Desmoid Tumor. You can view a list of Dr. Ana B. Oton's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Desmoid TumorDr. Oton isDistinguished. Learn about Desmoid Tumor.
- Experienced
- Lung CancerDr. Oton isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Oton isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).